Isomark Newsletter, April 2013

Isomark News
April 2013 The start of this year has been very busy for Isomark. We began by securing a bridge financing round, creating a medical advisory team, developing a regulatory pathway and planning our commercialization strategy. We look forward to accomplishing many milestones this year. Every few months we will update you on significant events. Best regards, Joe Kremer, CEO   BRIDGE ROUND COMPLETED Isomark recently completed an oversubscribed bridge round. This funding, along with future rounds, will help to cover funding requirements for building the business to a planned commercialization in 2015 of our breath monitoring technology. Thank you to our new investors who joined existing investors in finalizing the round. STATE of NEW YORK PROPOSES SEPSIS REGULATIONS The New York Times story about a boy whose sepsis went undiagnosed…
Read More

Isomark to be honored as a breakthrough technology at symposium

Isomark News
Isomark To Be Honored As A Breakthrough Technology Madison, Wis. – Isomark LLC, a medical device technology, was announced in early March as one of 30 breakthrough technologies to be honored at the sixth annual University Research and Entrepreneurship Symposium.  The URES will be held April 3 in the Microsoft New England Research and Development Center in Cambridge, Mass. The University Research and Entrepreneurship Symposium is an invitation-only event that showcases the top breakthrough technologies to leading New England venture capitalists and entrepreneurs.  Isomark and the University of Wisconsin-Madison will join the ranks of the 40 top research-driven universities such as Harvard, John Hopkins, MIT and UCLA. In five years of the URES, 13 companies have received $100 million in funding. “We are excited to be invited to present at…
Read More

Local pediatric doctor honored for study featuring Isomark technology.

Isomark News
FOR IMMEDIATE RELEASE (October 12, 2012) Contact: Dave Kruse, interim-CEO, Isomark, LLC at dave.kruse@isomark.com   Local Pediatric Doctor Honored For Landmark Study Featuring Isomark Technology Madison, WI – Isomark, LLC, a medical device technology company focused on early detection of life-threatening infections, announced today that UW-Madison pediatric critical-care physician Juan P. Boriosi, M.D., was honored at the 2012 Midwest Society for Pediatric Research Annual Meeting.  Dr. Boriosi’s work demonstrates the usefulness of Isomark’s breath biomarker for early detection of sepsis, a severe infection also known as blood poisoning. Dr. Boriosi received the Sutherland Award for the outstanding abstract presentation by a junior faculty member.  His presentation detailed the results of his study, which was conducted to test the effectiveness of Isomark’s early detection technology on diagnosing sepsis.  Sepsis is one…
Read More